A recent study indicates that individuals who discontinue popular weight-loss injections like Wegovy and Mounjaro can put back on reduced body mass at a significantly accelerated pace than those who halt conventional lifestyle regimens.
Findings released in a prominent health publication points out that while overweight people can lose a large proportion of their total mass while undergoing treatment, the weight returns at an average rate of 0.8 kg per month upon discontinuation.
"People buying these drugs should be aware of the danger of fast rebound weight gain when the medication ends," stated researcher Dr. Susan Jebb.
That rate of recovery implies a return to starting weight within about a year and a half.
Analyzing Therapies
The analysis, which reviewed 37 of studies involving thousands of patients, compared the outcomes of GLP-1 agonists with other pills.
The team emphasize that people who shed pounds through diet and exercise typically have a less rapid creep back—around 100 grams monthly—post-intervention.
The Reason for the Fast Rebound
Experts propose the mode of action of the drugs explains the accelerated rebound.
GLP-1 drugs mimic a body's own chemical called GLP-1, which controls hunger.
"Long-term administration of the hormone concentrations several times higher than the body's typical production may cause the body to generate a reduced amount of its endogenous hormone, and could lessen sensitivity to its effects," said Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this GLP-1 'fix' leads to appetite is unsuppressed, making overeating a significant risk."
A Lifelong Disease?
Health authorities suggest the injections for people with weight-linked medical conditions, alongside prescribed lifestyle changes.
Many experts contend that, given the significant potential of relapse, the therapy should be considered ongoing.
This perspective is echoed by drug manufacturers, who say that the findings "emphasize the long-term character of excess weight," comparing it to managing conditions like diabetes.
User Testimonies
Users who have stopped the jabs report a intense return of cravings.
"It felt as if a switch that goes on and you become extremely hungry," said a patient.
This challenge is worsened if individuals have not developed lasting lifestyle or habit changes during treatment.
Growing Adoption
Recent estimates show that millions of adults in the UK have tried these injections in the last 12 months, with desire remaining high.
- Use is higher among females compared to males.
- The 40s and 50s demographic shows the highest level of interest.
- Many access the medications through private healthcare rather than public health services.
Ultimately, researchers caution that while these medications are powerful tools for shedding pounds, they are not a magic solution and lasting health benefits relies on ongoing behavioural support.
